In 2010, researchers collected cancerous and normal tissue samples from eight ovarian cancer patients and identified and first reported ARID1A gene mutations by exome sequencing and Sanger sequencing in 57% of patients with clear cell carcinoma of the ovary. The gene discussed is ARID1A; the disease is ovarian carcinoma.